FDA decision will enable Iksuda to expand its ongoing clinical trial in the US, Australia and Singapore Preliminary data from an ongoing dose-escalation study of IKS014 has shown meaningful clinical ...

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Maharashtra FDA revoked Zepto's food license in Mumbai's Dharavi after a recent inspection which unveiled dangerous sights of non-compliance from the company's operator.

FDA’s public guidance continues to warn that, “under most circumstances,” importing drugs for personal use is unlawful, ...

Following positive opinion, Carthera is one of the first companies to benefit from brand-new status – intended to support early access pathways for innovative devices targeting rare diseasesParis, ...

The growing global burden of neuropsychiatric disorders is a critical driver for the treatment market. With over 9.1 million annual deaths attributed to neurological diseases and an additional 8 ...

Another Nebraska baseball player is heading to the transfer portal — this time while on a summer-ball assignment.

Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $108.

At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

AI-powered ChemPerturb-seq reveals sex-specific cocktail improving islet transplant survival, offering a new treatment for ...

A multistate outbreak of Listeria monocytogenes linked to chicken fettuccine alfredo has prompted a nationwide recall of ...